FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field
The first fecal microbiota product, Rebyota, approved by the U.S. Food and Drug Administration (FDA)…
December 1, 2022 - 6 minutes
Microbiome: An Emerging Field with Growing Investments
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Show More
Editor's Picks for Microbiome
- UK Startup Surfs Investment Wave in Microbiome with €18M Series A
- Microbiome Medicines Could Power Up CAR-T Cell Therapies
- Investing in the Microbiome in the Age of Covid-19 and Beyond
- The Missing Piece in the Microbiome Field
- No Guts, No Glory: How Microbiome Research is Changing Medicine
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportLatest Microbiome Articles
MaaT Pharma: leading the charge in microbiome therapeutics
The first generation of microbiome therapeutics is hitting its first approvals. Savita Bernal, chief business…
November 14, 2022 - 5 minutes
Persephone Biosciences studies the microbiome in baby poop
Disruption in the gut microbiome is linked to a wide range of health problems in…
October 28, 2022 - 6 minutes
Neobe Therapeutics breaks down tumor defenses with bacteria
Many cancer patients cannot benefit from cancer immunotherapy because their tumors are protected from the…
October 19, 2022 - 4 minutes
Clinical Microbiomics acquires MS-Omics
Clinical Microbiomics, a microbiome research company, has acquired MS-Omics, a metabolomics provider based in Denmark. …
October 17, 2022 - 2 minutes
Skin microbiome research could lead to new approaches for addressing organ damage after stem cell transplants
Skin microbiome research could lead to new approaches for addressing organ damage after stem cell…
October 13, 2022 - 3 minutes
License granted to EnteroBiotix for manufacture of microbiome product candidates
Microbiome therapeutics company, EnteroBiotix Limited has been granted a manufacturer’s license for a GMP manufacturing…
October 11, 2022 - 2 minutes
Clinical Microbiomics expanding with €10M million investment
Danish microbiome research company Clinical Microbiomics A/S has received €10 million ($9.7 million) in funding…
October 11, 2022 - 2 minutes
Novome Biotechnologies raises $43.5M for therapeutically engineered microbes pipeline
U.S. biotech company Novome Biotechnologies, Inc., has closed a $43.5 million series B financing round. …
September 15, 2022 - 3 minutes
NTU Singapore opens microbiome research center to study obesity and chronic diseases
Nanyang Technological University, Singapore (NTU Singapore) has created the Centre for Microbiome Medicine – a…
September 14, 2022 - 4 minutes
Sponsored
by Computomics
Metagenomics: unlocking the secrets of microbial communities
The combination of advanced sequencing technologies and user-friendly data analysis solutions is bringing metagenomics into…
August 30, 2022 - 6 minutes
Bayer Consumer Health launches microbiome research call to find new academic partners
Campaign launch date: Monday, July 18, 2022. Bayer Consumer Health has launched a call through…
July 19, 2022 - 3 minutes
